Duojia Cao

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.

A. Pawłowski, B. Johansson‐Lindbom, D. Bell, 2021, Vaccine.

A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains

A. Pawłowski, M. Hedegaard, B. Johansson‐Lindbom, 2022, Cell reports. Medicine.

Seroprevalence of Toxoplasma gondii infection in dairy goats in Shaanxi Province, Northwestern China

Xing-Quan Zhu, Miaotao Zhang, De-kun Chen, 2011, Parasites & Vectors.

Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial

A. Pawłowski, M. Darsley, M. Gonzalez-Miro, 2023, iScience.